Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

AI has already disrupted fields like coding, investment banking and law, but it looks to be poised to change yet another ...

Not many children dream of winning a Nobel Prize when they grow up, but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

according to Demis Hassabis, a co-winner of this year’s prize in chemistry. Hassabis, 48, CEO and co-founder of Google DeepMind, developed the AI model AlphaFold to predict protein structure ...

Researchers are identifying current and future dangers within AI models away from the conflicts of interest they’d face in ...

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in Anthropic, a ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...